| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.0B | $13.7B | $13.9B | $12.8B | $12.4B | $11.7B | $3.1B | $3.0B |
| Cost of Revenue | $6.9B | $7.1B | $7.3B | $7.0B | $6.2B | $5.9B | $1.5B | $1.6B |
| Gross Profit | $4.3B | $4.5B | $4.4B | $3.7B | $4.1B | $3.8B | $1.0B | $0.8B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.6B | $2.7B | $2.8B | $2.6B | $2.6B | $2.4B | $2.7B | $2.8B |
| Operating Income | $-2.3B | $1.8B | $1.4B | $0.2B | $1.5B | $-0.4B | $0.8B | $1.6B |
| Net Income | $-2.1B | $1.1B | $0.9B | $-0.2B | $1.0B | $-0.9B | $0.2B | $0.1B |
| EPS (Basic) | $-10.75 | $5.38 | — | — | — | — | — | — |
| EPS (Diluted) | $-10.75 | $5.35 | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $22.7B | $26.1B | $26.4B | $25.9B | $27.6B | $27.3B | $28.9B | $30.1B |
| Current Assets | $2.9B | $2.8B | $2.8B | $2.6B | $2.8B | $2.4B | $2.2B | $2.8B |
| Cash & Equivalents | $0.9B | $1.0B | $0.9B | $0.6B | $0.6B | $0.8B | $0.5B | $1.1B |
| Total Liabilities | $12.2B | $12.6B | $12.9B | $13.0B | $14.0B | $14.7B | $15.2B | $16.4B |
| Current Liabilities | $5.3B | $3.0B | $4.1B | $3.4B | $3.6B | $3.9B | $3.7B | $4.3B |
| Stockholders' Equity | $10.2B | $13.1B | $13.2B | $12.7B | $13.4B | $12.4B | $13.4B | $13.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.8B | $1.9B | $2.1B | $1.5B | $1.6B | $1.7B | $1.9B | $2.3B |
| Investing Cash Flow | $-0.8B | $-0.6B | $-0.8B | $-0.6B | $-0.5B | $-0.4B | $-0.4B | $-0.7B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.1B | $-1.1B | $-1.0B | $-0.9B | $-1.2B | $-1.1B | $-2.0B | $-1.0B |